Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3Phase 1/2 2

Status

Terminated 2Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 4Tumor-Agnostic 1Thoracic 1

Conditions

Breast Neoplasms 91Carcinoma, Non-Small-Cell Lung 53Lung Neoplasms 22Hodgkin Disease 15Recurrence 11Lymphoma 10Neoplasm Metastasis 9Prostatic Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasms 6Sarcoma 4Rhabdomyosarcoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Adenocarcinoma of Lung 4Multiple Myeloma 3Mesothelioma, Malignant 3Mesothelioma 3Breast Neoplasms, Male 3Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Melanoma 2Lymphoma, Large-Cell, Anaplastic 2HER2-negative Breast Cancer 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Brain Neoplasms 2Advanced Breast Cancer 2

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Vinorelbine × Clear all
NCT05999994 2026-03-27

CAMPFIRE

Eli Lilly and Company

Phase 2 Recruiting
105 enrolled
Tumor-Agnostic

Neoplasms

NCT04759248 2025-09-09

ATREZZO

SOLTI Breast Cancer Research Group

Phase 2 Active not recruiting
55 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT02117024 2020-02-05

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Heat Biologics

Phase 2 Terminated
66 enrolled 17 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01013740 2017-05-31

VITAL

Novartis

Phase 2 Completed
112 enrolled 15 charts
Breast

Breast Neoplasms, Neoplasms

NCT01128543 2012-12-12

Lapatinib in Combination With Vinorelbine

GlaxoSmithKline

Phase 2 Completed
29 enrolled 8 charts
Breast

Breast Neoplasms, Neoplasms

NCT00453635 2012-03-13

Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

Hellenic Oncology Research Group

Phase 2 Terminated
88 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡